SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Trump Media & Technology Group Corp. engages in operating social media and in the technology business. Its brands include TRUTH Social, TMTG+ and TMTG News. The company was founded on March 28, 2024 and is headquartered in Sarasota, FL.

Trump Media & Technology Group Corp.

Trump Media & Technology Group (DJT) is drawing significant attention following a recent all-stock merger announcement with fusion energy company TAE Technologies, valued at over $6 billion. This surprising move into cutting-edge energy, framed by some as a major catalyst for AI power demand and a potential short squeeze, is equally met with community skepticism calling it a "scam" or "grift" due to the unusual business combination.

Micron Technology, Inc. engages in the provision of innovative memory and storage solutions. It operates through the following segments: Compute and Networking Business Unit (CNBU), Mobile Business Unit (MBU), Embedded Business Unit (EBU), and Storage Business Unit (SBU). The CNBU segment includes memory products and solutions sold into client, cloud server, enterprise, graphics, and networking markets. The MBU segment is involved in memory and storage products sold into smartphone and other mobile-device markets. The EBU segment focuses on memory and storage products sold into automotive, industrial, and consumer Markets. The SBU segment consists of SSDs and component-level solutions sold into enterprise and cloud, client, and consumer storage markets. The company was founded by Ward D. Parkinson, Joseph Leon Parkinson, Dennis Wilson, and Doug Pitman on October 5, 1978 and is headquartered in Boise, ID.

Micron Technology Inc.

Micron Technology Inc

Micron (MU) is trending after delivering a blockbuster earnings report and exceptionally strong guidance, significantly surpassing analyst expectations. This performance is largely driven by robust demand for AI-driven memory, with the company indicating High-Bandwidth Memory (HBM) is fully committed through 2026. The community is actively discussing impressive margin expansion, potential new all-time highs, and numerous analyst price target increases, which is bolstering optimism for the broader AI sector.

Tilray Brands, Inc. engages as a consumer packaged goods company, which focuses on medical cannabis research and the cultivation, processing, and distribution of cannabis products worldwide. It operates through the followings segments: Cannabis, Distribution, Beverage, and Wellness. The Cannabis segment focuses on cultivation, production, distribution, and sale of both medical and adult-use cannabis products. The Distribution segment is involved in purchase, resale, and distribution of pharmaceutical and wellness products. The Beverage segment refers to the production, marketing, and sale of beverages. The Wellness segment represents the production, marketing, and distribution of hemp-based food and other wellness products. The company was founded on January 24, 2018 and is headquartered in Leamington, Canada.

Tilray Brands Inc

Tilray Brands is currently trending amid widespread anticipation of an imminent Executive Order to reclassify cannabis to Schedule III, a move seen by many as a monumental shift for the entire sector. The community is buzzing with speculation about a potential short squeeze, significant institutional investment, and the elimination of 280E tax burdens, while some express caution about a 'sell the news' event or the direct impact on Canadian operators. This potential regulatory change is widely viewed as a foundational step to unlock new opportunities and reshape the cannabis market.

Athira Pharma, Inc. engages in the development of small molecules to restore neuronal health and stop neurodegeneration. Its product pipeline includes ATH-1017, ATH-1019/20, and ATH-1018. The company was founded by Leen Kawas, John Wright, Lewis Rumpler, and Joseph Harding in March 2011 and is headquartered in Bothell, WA.

Athira Pharma Inc

Athira Pharma is trending with strong momentum after announcing an exclusive license for a Phase 3 breast cancer drug candidate and securing substantial new financing from institutional investors. This strategic pivot into oncology, combined with the stock's relatively low float, is driving community discussions focused on significant upside potential and a possible short squeeze.

FuelCell Energy, Inc. engages in the business of developing, designing, producing, constructing, and servicing high temperature fuel cells for clean electric power generation. It operates through the following geographical segments: the United States, South Korea, and Europe. The company was founded by Bernard Baker and Martin G. Klein in 1969 and is headquartered in Danbury, CT.

Fuelcell Energy Inc

FuelCell Energy is trending following a positive earnings report that has generated significant bullish momentum and active discussion around its technical indicators, with many anticipating a breakout. The community is focused on the company's potential to provide power solutions for the rapidly growing AI data center market, drawing comparisons to other fuel cell sector players. While optimism is high for new growth opportunities and a shift in trajectory, some investors remain cautious, highlighting historical dilution and the importance of securing substantial new contracts to validate long-term prospects.

Super Micro Computer, Inc. engages in the distribution and manufacture of information technology solutions and other computer products. Its products include twin solutions, MP servers, GPU and coprocessor, MicroCloud, AMD solutions, power supplies, SuperServer, storage, motherboards, chassis, super workstations, accessories, SuperRack and server management products. The company was founded by Charles Liang, Yih-Shyan Liaw, Sara Liu, and Chiu-Chu Liu Liang in September 1993 and is headquartered in San Jose, CA.

Super Micro Computer Inc

Super Micro Computer is a major discussion point as it solidifies its role as a leader in AI infrastructure, propelled by new partnerships and substantial revenue growth targets for its advanced server solutions. However, ongoing volatility sparks polarized community views, with many citing deep undervaluation and market manipulation amidst positive sector news, while others express frustration over the stock's performance despite its strong AI narrative.

Advisorshares Trust - AdvisorShares Pure US Cannabis ETF

AdvisorShares Pure US Cannabis ETF

The AdvisorShares Pure US Cannabis ETF ($MSOS) is surging on widespread anticipation of an Executive Order to reschedule cannabis to Schedule III, a federal reform that would significantly ease regulatory burdens, including the punitive 280E tax. The community is expressing strong bullish sentiment, expecting this landmark change to unlock substantial institutional investment and catalyze significant growth for US multi-state operators.

Lucid Group, Inc. manufactures electric vehicles. It designs, develops, and builds energy storage systems for electric vehicles and supplies automakers with the battery pack system needed to power hybrid, plug-in, and electric vehicles. The company was founded in December 2007 and is headquartered in Newark, CA.

Lucid Group Inc

Lucid Group is trending amid polarized investor sentiment, driven by a recent analyst downgrade and critical product reviews highlighting software issues, while bulls point to new vehicle awards and significant institutional buying. The community remains divided, with strong calls for a new CEO to address concerns over dilution and continuous stock declines, hoping for a short squeeze despite ongoing bearish pressure and comparisons to other EV rivals.

Sable Offshore Corp. engages in offshore oil and gas field operations. It focuses on developing the prolific Santa Ynez Unit in federal waters offshore California. The company was founded by James C. Flores on October 16, 2020 and is headquartered in Houston, TX.

Sable Offshore Corp.

Sable Offshore Corp. is trending due to recent confirmation from the U.S. Department of Transportation that its Santa Ynez Unit pipeline is an interstate facility, shifting regulatory authority to federal oversight. This development has ignited strong bullish sentiment within the community, with many anticipating substantial upside and a potential short squeeze as operational hurdles may diminish. Nevertheless, some market participants remain wary of the company's financial structure and ongoing challenges with state-level approvals.

CorMedix, Inc. is a pharmaceutical and medical device company, which engages in the development and commercialization of therapeutic products for the prevention and treatment of diseases and conditions. The company was founded by Antony E. Pfaffle on July 28, 2006 and is headquartered in Berkeley Heights, NJ.

CorMedix Inc

CorMedix is trending as the market anticipates the release of crucial Real World Evidence data for its product, DefenCath, expected to validate significant reductions in catheter-related bloodstream infections and substantial cost savings for healthcare providers. Despite community enthusiasm for DefenCath's proven efficacy and market potential, there's widespread frustration over the stock's constrained price performance, frequently attributed to high short interest and perceived market manipulation. Investors are eagerly awaiting whether this RWE readout will finally drive broader adoption and a re-rating of the company's valuation.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Akouos is a biotechnology company focusing on restoring and preserving hearing. The company leverages adeno-associated viral (AAV) vector-based gene therapy in order to restore and preserve hearing in genetically-defined patient populations in a range of forms, from a single genetic mutation to ototoxic drug exposure and to the aging process, enabling the healthcare industry to treat sensorineural hearing loss in an efficient manner.

Akouos Inc

Up more than 2%

Up 0–2%

Flat to down 2%

Down more than 2%

The S&P 500 is modestly lower so far in December, putting the Santa Claus rally in question. The Santa Claus rally refers to the market’s tendency to rise in the final weeks of the year—what do you expect from December 16 through December 31?

What do you expect the S&amp;P 500’s total return to be in the second half of December?

Stocktwits

What do you expect the S&P 500’s total return to be in the second half of December?

AKUS
Akouos Inc

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest AKUS News

AKUSAkouos Inc